Related Experiment Video
Updated: Sep 13, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Reducing stigma and expanding methadone access in the U.S.: the Modernizing Opioid Treatment Access Act and beyond
Julio C Nunes1, Bryon Adinoff2
1Department of Psychiatry, Yale University, New Haven, CT, USA.
Abstract:
The Modernizing Opioid Treatment Access (MOTA) Act proposes reforms to methadone regulation by allowing addiction physician specialists to prescribe up to 30-day doses through community pharmacies. This perspective examines the bill's implications, implementation challenges, and future policy directions to improve equitable access to methadone. While opioid treatment programs have played a critical role in methadone delivery, their restrictive model can increase stigma and limit access, particularly in underserved areas. The COVID-19 pandemic demonstrated that 30-day take-home methadone-dispensed through opioid treatment programs-could be implemented safely in the U.S. and international pharmacy-dispensing models further support a less restrictive approach. However, successful implementation requires addressing inadequate prescriber training, pharmacy participation barriers, and insurance coverage limitations. Expanding methadone access through pharmacies is a step toward integrating addiction treatment into mainstream healthcare. If able to effectively increase accessibility, the MOTA Act may also help reduce stigma and improve outcomes for individuals with opioids use disorder.
Insights
The Modernizing Opioid Treatment Access (MOTA) Act could improve methadone access by allowing prescriptions via pharmacies. This reform aims to reduce stigma and increase equitable treatment for opioid use disorder.
Area of Science:
- Public Health
- Addiction Medicine
- Healthcare Policy
Background:
- Opioid treatment programs (OTPs) are crucial for methadone delivery but can create barriers to access and increase stigma.
- Restrictive methadone regulations limit patient access, particularly in underserved communities.
Purpose of the Study:
- To examine the implications, challenges, and policy directions of the Modernizing Opioid Treatment Access (MOTA) Act.
- To assess the potential of the MOTA Act to improve equitable access to methadone via community pharmacies.
Main Methods:
- This is a perspective piece, analyzing proposed legislative changes and existing evidence.
- It reviews the role of OTPs, the impact of the COVID-19 pandemic on methadone access, and international pharmacy-dispensing models.
Main Results:
- The MOTA Act proposes allowing addiction specialists to prescribe 30-day methadone doses through pharmacies, moving away from the traditional OTP model.
- The COVID-19 pandemic demonstrated the safety of 30-day take-home methadone, and international models support pharmacy dispensing.
Conclusions:
- Successful implementation of the MOTA Act requires addressing prescriber training, pharmacy participation, and insurance coverage.
- Expanding methadone access through pharmacies can integrate addiction treatment into mainstream healthcare, potentially reducing stigma and improving outcomes for opioid use disorder.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Receptors: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...